You have 9 free searches left this month | for more free features.

Condition

Bipolar Disorder (2)

Major Depressive Disorder (1)

Overall Status

Active, not recruiting (1)

Completed (1)

Recruiting (1)

Sign in for free

Phase

phase 2 (2)

n/a (1)

Sponsor

Herbert Meltzer (1)

Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (1)

King's College London (1)

Collaborator

Janssen Research & Development, LLC (1)

Intervention

jnj-18038683 (3)

placebo (2)

escitalopram (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Other (2)

Industry (1)

Study Type

Interventional (3)

jnj-18038683

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Bipolar Disorder Trial in Chicago (JNJ-18038683)

Active, not recruiting

Bipolar Disorder

JNJ-18038683

Chicago, Illinois

Mahdi Arshadi

Jan 18, 2022

Bipolar Disorder Trial in London (JNJ-18038683, Placebo)

Recruiting

Bipolar Disorder

JNJ-18038683
Placebo

London, United Kingdom

King's College London

Sep 6, 2021

MDD Trial in United States (Placebo, Escitalopram, JNJ-18038683)

Completed

Major Depressive Disorder

Placebo
+2 more

Little Rock, Arkansas
+25 more

Aug 1, 2014